GeneCentric Lands $2,500,005 New Financing

  • Feed Type
  • Date
    7/11/2014
  • Company Name
    GeneCentric
  • Mailing Address
    280 S. Mangum Street Durham, NC 27701 USA
  • Company Description
    The mission of GeneCentric Diagnostics is to develop and commercialize novel molecular diagnostic assays that enable oncologists and their patients make more informed, individualized treatment decisions.
  • Website
    http://www.genecentric.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,500,005
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor